Overview
Cryoglobulinemic glomerulonephritis is a renal manifestation characterized by the deposition of cryoglobulins in the glomeruli, often associated with hepatitis C virus (HCV) infection, leading to immune complex-mediated kidney damage. 1Diagnosis
Serological Testing: Elevated levels of mannose-binding lectin (MBL) in serum compared to controls. 1
Renal Biopsy: Essential for definitive diagnosis; shows deposition of IgG, IgM, MBL, MASP-1, C4d, C3c, and C3d in a fringe-like pattern within glomeruli. 1
Immunohistochemistry: Useful for visualizing complement pathway components and cryoglobulins in biopsy specimens. 1
Complement Profile: Reduced serum levels of C1q, C2, and C3, with normal levels of C1-inhibitor, factor H, and factor I; significantly reduced C4 levels. 1Management
Antiviral Therapy: Targeting HCV infection with direct-acting antivirals (DAAs) to reduce cryoglobulin levels and improve renal outcomes. 1 (Evidence: Moderate)
Immunosuppressive Therapy: Rituximab or other B-cell depleting agents may be considered for refractory cases or severe renal involvement. 1 (Evidence: Weak)
Corticosteroids: Used in conjunction with immunosuppressive agents for acute exacerbations or severe inflammation. 1 (Evidence: Weak)
Plasma Exchange: Indicated in acute severe kidney injury or rapidly progressive glomerulonephritis. 1 (Evidence: Weak)Special Populations
HCV Infection: All patients in the study had HCV infection, highlighting its central role in pathogenesis. 1
No Specific Data: Limited information provided regarding pregnancy, pediatrics, elderly, or specific comorbidities beyond HCV. 1Key Recommendations
Perform serum MBL levels and renal biopsy with immunohistochemistry to confirm diagnosis. (Evidence: Moderate) 1
Initiate antiviral therapy targeting HCV to manage underlying infection and potentially improve renal function. (Evidence: Moderate) 1
Consider immunosuppressive or B-cell depleting therapies for patients with refractory or severe renal involvement. (Evidence: Weak) 1References
1 Ohsawa I, Ohi H, Tamano M, Endo M, Fujita T, Satomura A et al.. Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway. Clinical immunology (Orlando, Fla.) 2001. link